Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Cathie Wood reveals why she steered clear of Arm IPO frenzy

"We did not participate in that IPO."

Fortune

Instacart shares jump 43% in grocery delivery business’s Nasdaq debut

Shares close at $34.23, the second successful IPO in a week following sale of UK chip designer Arm

The Guardian - US

Bionano Genomics (BNGO) vs. Gilead Sciences (GILD): Buy, Hold or Sell these Biotech Stocks?

As the biotech industry reaches new heights with innovation and the accessibility of big data, let us analyze whether biotech stocks Bionano Genomics and Gilead Sciences are a Buy, Hold, or Sell.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Jim Chanos Thinks Tesla Stock Is ‘Ridiculously Overvalued

Jim Chanos confirmed he still has an active short bet against Tesla, Inc

Zenger

Markets Today: Stocks Slip on Higher Bond Yields and Chip Stock Weakness

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.08%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.25%. Stock index futures this morning are mixed. Stock index futures gave up overnight gains and turned lower as bond yields rose after a measure of...

Barchart

UK chip designer Arm soars on Nasdaq debut to notch $65bn valuation

Investor appetite for shares in SoftBank-owned tech firm pushes shares up close to 25% in much-hyped initial public offering

The Guardian - US

What a crop of upcoming IPOs from Birkenstock to Instacart tells us about the economy

A crop of IPOs are coming, starting with chip designer Arm, which is making its debut on Thursday. It's another sign of confidence in markets — and the U.S. economy.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Jim Cramer ‘Not Convinced’ Tesla’s Dojo Can Rival Nvidia As He Tears Into Morgan’s Stock Upgrade

Tesla, Inc. ran up over 10% on Monday after Morgan Stanley's Adam Jonas upgraded the stock and issued a Street-high price target.

Zenger

Google’s Race For AI Dominance Against Microsoft Still On, Alphabet CEO Sundar Pichai Suggests

Pichai reaction after Satya Nadella's “we made them dance” comment in reference to the AI competition between the tech giants.

Zenger

S&P Futures Tick Higher as Investors Weigh Interest Rate Outlook

September S&P 500 futures (ESU23) are trending up +0.08% this morning after the S&P 500 and Nasdaq closed in the red on Thursday as technology stocks dropped on concerns over the outlook for Apple, while the latest U.S. jobless claims data stoked worries about sticky inflation.

Barchart

S&P Futures Tick Lower as Interest Rate Uncertainty Weighs on Sentiment

September S&P 500 futures (ESU23) are trending down -0.24% this morning after the S&P 500 and Nasdaq closed in the red on Thursday as technology stocks dropped on concerns over the outlook for Apple, while the latest U.S. jobless claims data stoked worries about sticky inflation.

Barchart

S&P Futures Tick Lower as Investors Weigh Interest Rate Outlook

September S&P 500 futures (ESU23) are trending down -0.24% this morning after the S&P 500 and Nasdaq closed in the red on Thursday as technology stocks dropped on concerns over the outlook for Apple, while the latest jobless claims data stoked worries about sticky inflation.

Barchart

Arm prices hotly anticipated Nasdaq IPO lower than initially expected after London snub

Arm will sell its shares for between $47 and $51, aiming to raise up to $4.87 billion

Evening Standard

Arm’s move to Nasdaq not all plain sailing as US market shows scepticism on IPOs

The chipmaker’s price tag was once touted as $70bn, then $64bn, but is now expected to be between $50bn and $55bn

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

UK chip designer Arm ‘cuts target valuation before Nasdaq listing’

Company said to be eyeing $50bn-$55bn compared with $64bn its owner Softbank stated last month

Barchart

3 Mega-Cap Stocks to Buy in September

Tech stocks faltered in August after a searing rally to start 2023. Here are three mega-cap tech stocks that are trading at attractive levels for investors looking to buy the dip.

Zenger

Tesla’s Aggressive Price Cuts, VinFast’s Rise And Fall, And More: Biggest EV Stories Of The Week

Shares of electric vehicle makers closed the week ending Sept. 1 mostly higher; Tesla experienced volatility over price cut fears

Fortune

Arm, Instacart, Klaviyo to lead IPO market this fall

Positive debuts from the trio of tech stars could help kick open the IPO floodgates

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

3 Standout Tech Stocks That Hit New Highs in August

The broader Nasdaq pulled back in August, but these three tech stocks bucked the trend to find new highs during the month. Here's why.

Zenger

Elon Musk’s ‘X’ To Introduce Biometric Data Collection In Updated Privacy Policy, Raising Concerns

The Company's privacy policy evolution sees biometric data as key to enhanced job recommendations and tailored advertising

Zenger

Federal Reserve Discreetly Pushes US Regional Banks For Enhanced Liquidity Planning

Regulatory scrutiny has tightened following the failures of First Republic Bank, Silicon Valley Bank and Signature Bank.

Zenger

Cathie Wood’s Ark ETFs Gain More Than $600 Million In A Single Day

Impetus for the surge came from a widespread rally in both crypto-related and electric vehicle stocks.

Barchart

3 Retailers Hitting 52-Week High: Care to Guess Which Is the Buy?

All the major U.S. exchanges are up in Tuesday trading. Approximately 30 stocks on the NYSE and Nasdaq hit 52-week highs including three well-known retailers. Only one of them is a buy.

StockNews.com

Clover Health Investments (CLOV) vs. Cigna (CI): Which Medical Stock is the Bigger Buy?

The ever-rising healthcare costs are boosting the insurance industry in the current economic landscape. While prominent industry players Clover Health (CLOV) and Cigna Group (CI) should benefit, let us analyze which is the bigger buy.

The Week

The AI stock market wave: chancing an Arm?

If ever a float could be said to test current market conditions, it may be that of Arm, the SoftBank-owned British chip designer that has “started the countdown” for a Nasdaq IPO in early September, said the FT.

1 … 220 221 222 223

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.